Back To Schedule
Tuesday, June 20 • 4:00pm - 5:00pm
#272: Microbiome: Innovative Therapeutics, Challenges, and Opportunities

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Component Type: Forum
Level: Intermediate
CE: CME 1.00; IACET 1.00; RN 1.00

Emerging research points to the significant role of microbiome in contributing to disease and how promoting maintenance of a “healthy microbiome” across a wide variety of disease states can maintain health, prevent, intercept, and treat disease states. How do we handle the complexity of the microbiome in conducting clinical research and monitoring? Does addressing the microbiome impact how we view disease and clinical practice? Do we need new regulatory and medical approaches to manage?

Learning Objectives

Describe the complexity of the microbiome in both health and disease management; Identify how addressing the microbiome can fundamentally change our approach to medicine.


Caroline B. Kurtz, PhD


Overview of the Microbiome and Approaches to Therapeutic Development
Caroline B. Kurtz, PhD

Regulatory Aspects of Microbiome Product Development
James R. Weston, MBA

Clinical Development Challenges for Microbiome Drug Development
Paul K. Plumb

avatar for Caroline Kurtz

Caroline Kurtz

Head of Translational Science and Product Development, Synlogic
Dr. Caroline Kurtz is Head of Translational Sciences at Synlogic. Previously, Caroline was a Vice President at Ironwood Pharmaceuticals, where she led the development of linaclotide (LINZESS®). Prior to her role at Ironwood, Caroline served as Director of Infectious Diseases at GelTex/Genzyme... Read More →


Paul Plumb

Head of Clinical Operations, Rebiotix, Inc.
Paul K. Plumb is the Head of Clinical Operations at Rebiotix, a clinical-stage microbiome company focused on harnessing the power of the human microbiome to revolutionize the treatment of challenging diseases. Paul has over 30 years of medical technology and healthcare delivery experience... Read More →

James Weston

Vice President, Regulatory Affairs, Seres Therapeutics, Inc.
Jim Weston is a veteran regulatory affairs and quality executive with a demonstrated ability to spearhead the drug development process by crafting effective regulatory and clinical strategies world-wide, including the US, Canada, Europe (centralized and member states), Australia and... Read More →

Tuesday June 20, 2017 4:00pm - 5:00pm CDT
S502ab McCormick Place 2301 South Martin Luther King Jr. Drive, Gate 4 Chicago, IL 60616
  02: DisruptiveInnov, Forum